Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2017 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Evaluating FMX-101 as a promising therapeutic for the treatment of acne.
Valente Duarte de Sousa IC. Valente Duarte de Sousa IC. Expert Opin Pharmacother. 2020 May;21(7):741-746. doi: 10.1080/14656566.2020.1721461. Epub 2020 Feb 8. Expert Opin Pharmacother. 2020. PMID: 32037906 Review.
INTRODUCTION: Oral minocycline is a mainstay of therapy for moderate-to-severe acne; however, systemic side effects which include hepatotoxicity, lupus-like syndrome, drug hypersensitivity syndrome, autoimmune hepatitis, polyarteritis nodosa, gastrointestinal side e …
INTRODUCTION: Oral minocycline is a mainstay of therapy for moderate-to-severe acne; however, systemic side effects which include hep …
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus.
Kishida D, Sato M, Kobayashi C, Ueno KI, Kinoshita T, Kodaira M, Shimojima Y, Ishii W, Ushiki A, Ikeda SI. Kishida D, et al. Intern Med. 2017;56(10):1253-1257. doi: 10.2169/internalmedicine.56.8053. Epub 2017 May 15. Intern Med. 2017. PMID: 28502947 Free PMC article.
Mycobacterium abscessus infection tends to occur in patients with an advanced immunocompromised status. We encountered a case of intractable cutaneous M. abscessus infection that developed in a patient with systemic lupus erythematosus (S …
Mycobacterium abscessus infection tends to occur in patients with an advanced immunocompromised status. We encountered a case of intr …
Cutaneous Mycobacterium haemophilum infections in immunocompromised patients in a dermatology clinic in Singapore.
Tan HH, Tan A, Theng C, Ng SK. Tan HH, et al. Ann Acad Med Singap. 2004 Jul;33(4):532-6. Ann Acad Med Singap. 2004. PMID: 15329772 Free article.
INTRODUCTION: Mycobacterium haemophilum, a nontuberculous mycobacterium (NTM) that was first described in 1978, is a pathogen that can cause an array of symptoms in immunocompromised patients, predominantly cutaneous. CLINICAL PICTURE: We report our hospital' …
INTRODUCTION: Mycobacterium haemophilum, a nontuberculous mycobacterium (NTM) that was first described in 1978, is a pathogen that can cause …
Feedback